Comparative study of equine mesenchymal stem cells from healthy and injured synovial tissues: an in vitro assessment

• Published in: Stem cell research & therapy Vol. 7; no. 1; p. 35
• Main Authors: Fülber, Joice, Maria, Durvanei A, da Silva, Luis Cláudio Lopes Correia, Massoco, Cristina O, Agreste, Fernanda, Baccarin, Raquel Y Arantes
• Format: Journal Article
• Language: English
• Published: England BioMed Central 05-03-2016
• Subjects: Animals; Antigens, CD - metabolism; Carcinogenicity Tests; Cells, Cultured; Female; Horse Diseases - pathology; Horse Diseases - therapy; Horses; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stromal Cells - physiology; Mice, Inbred BALB C; Mice, Nude; Osteoarthritis - pathology; Osteoarthritis - therapy; Osteoarthritis - veterinary; Synovial Fluid
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-016-0294-3

Bone marrow and adipose tissues are known sources of mesenchymal stem cells (MSCs) in horses; however, synovial tissues might be a promising alternative. The aim of this study was to evaluate phenotypic characteristics and differentiation potential of equine MSCs from synovial fluid (SF) and synovial membrane (SM) of healthy joints (SF-H and SM-H), joints with osteoarthritis (SF-OA and SM-OA) and joints with osteochondritis dissecans (SF-OCD and SM-OCD) to determine the most suitable synovial source for an allogeneic therapy cell bank.
Expression of the markers CD90, CD105, CD44, and CD34 in SF-H, SM-H, SF-OA, SM-OA, SF-OCD and SM-OCD was verified by flow cytometry, and expression of cytokeratin, vimentin, PGP 9.5, PCNA, lysozyme, nanog, and Oct4 was verified by immunocytochemistry. MSCs were cultured and evaluated for their chondrogenic, osteogenic and adipogenic differentiation potential. Final quantification of extracellular matrix and mineralized matrix was determined using AxioVision software. A tumorigenicity test was conducted in Balb-C(nu/nu) mice to verify the safety of the MSCs from these sources.
Cultured cells from SF and SM exhibited fibroblastoid morphology and the ability to adhere to plastic. The time elapsed between primary culture and the third passage was approximately 73 days for SF-H, 89 days for SF-OCD, 60 days for SF-OA, 68 days for SM-H, 57 days for SM-OCD and 54 days for SM-OA. The doubling time for SF-OCD was higher than that for other cells at the first passage (P < 0.05). MSCs from synovial tissues showed positive expression of the markers CD90, CD44, lysozyme, PGP 9.5, PCNA and vimentin and were able to differentiate into chondrogenic (21 days) and osteogenic (21 days) lineages, and, although poorly, into adipogenic lineages (14 days). The areas staining positive for extracellular matrix in the SF-H and SM-H groups were larger than those in the SF-OA and SM-OA groups (P < 0.05). The positive mineralized matrix area in the SF-H group was larger than those in all the other groups (P < 0.05). The studied cells exhibited no tumorigenic effects.
SF and SM are viable sources of equine MSCs. All sources studied provide suitable MSCs for an allogeneic therapy cell bank; nevertheless, MSCs from healthy joints may be preferable for cell banking purposes because they exhibit better chondrogenic differentiation capacity.